Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 2
1978 1
1983 2
1985 2
1986 3
1989 1
2005 1
2007 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
[Oculomucocutaneous syndrome].
Böke W. Böke W. Fortschr Ophthalmol. 1986;83(1):51-64. Fortschr Ophthalmol. 1986. PMID: 3710354 German. No abstract available.
Chronic granulomatous disease presenting as an oculomucocutaneous syndrome mimicking Behçet's syndrome.
Kelleher D, Bloomfield FJ, Lenehan T, Griffin M, Feighery C, McCann SR. Kelleher D, et al. Postgrad Med J. 1986 Jun;62(728):489-91. doi: 10.1136/pgmj.62.728.489. Postgrad Med J. 1986. PMID: 3774683 Free PMC article.
A female patient who presented for the first time at the age of 19 with oculomucocutaneous syndrome was found to have an absolute deficiency of neutrophil peroxide production. ...The diagnosis of chronic granulomatous disease should be considered in young patients w …
A female patient who presented for the first time at the age of 19 with oculomucocutaneous syndrome was found to have an absol …
Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome.
Amos HE, Lake BG, Artis J. Amos HE, et al. Br Med J. 1978 Feb 18;1(6110):402-4. doi: 10.1136/bmj.1.6110.402. Br Med J. 1978. PMID: 146533 Free PMC article.
The clinical distribution of an antibody to a metabolite of practolol was investigated, particularly in relation to the oculomucocutaneous syndrome. Serum samples were obtained from patients with and without a history of adverse reaction to practolol and two groups …
The clinical distribution of an antibody to a metabolite of practolol was investigated, particularly in relation to the oculomucocutaneou …
Slow-release artificial tear inserts in the treatment of dry eyes resulting from the oculomucocutaneous syndrome.
Wright P, Vogel R. Wright P, et al. Br J Ophthalmol. 1983 Jun;67(6):393-7. doi: 10.1136/bjo.67.6.393. Br J Ophthalmol. 1983. PMID: 6849861 Free PMC article.
Patients with dry eyes resulting from the practolol syndrome present a therapeutic challenge. Very frequent instillation of preservative-free drops are the only therapy in most cases. ...
Patients with dry eyes resulting from the practolol syndrome present a therapeutic challenge. Very frequent instillation of preservat …
An instructive example of a long-latency adverse drug reaction--sclerosing peritonitis due to practolol.
Mann RD. Mann RD. Pharmacoepidemiol Drug Saf. 2007 Nov;16(11):1211-6. doi: 10.1002/pds.1466. Pharmacoepidemiol Drug Saf. 2007. PMID: 17853493
OBJECTIVE: By examination of the original Yellow Card data to determine the duration of the latent period of the sclerosing peritonitis which formed part of the oculomucocutaneous syndrome that was associated with practolol, the beta-adrenergic receptor blocking age …
OBJECTIVE: By examination of the original Yellow Card data to determine the duration of the latent period of the sclerosing peritonitis whic …
Ocular, systemic and antinuclear antibody changes with acebutolol.
Hosie J, Ghafoor SY. Hosie J, et al. J R Coll Gen Pract. 1983 Dec;33(257):779-82. J R Coll Gen Pract. 1983. PMID: 6606705 Free PMC article.
One patient had a slight worsening of her psoriasis. No patients developed any symptoms or signs of oculomucocutaneous syndrome (OMCS) or systemic lupus erythematosus (SLE)....
One patient had a slight worsening of her psoriasis. No patients developed any symptoms or signs of oculomucocutaneous syndrome …
Adverse reactions and interactions with beta-adrenoceptor blocking drugs.
Lewis RV, McDevitt DG. Lewis RV, et al. Med Toxicol. 1986 Sep-Oct;1(5):343-61. doi: 10.1007/BF03259848. Med Toxicol. 1986. PMID: 2878346 Review.
Long term experience with many of the beta-blockers in current use suggests that unpredictable major adverse reactions such as the practolol oculomucocutaneous syndrome are unlikely to be repeated, although some of these drugs may be associated with immunological di …
Long term experience with many of the beta-blockers in current use suggests that unpredictable major adverse reactions such as the practolol …
14 results